Skip to content

Study of Gulf War Illness (GWI) by Comparing GWI and Healthy Veterans

CNDP1 Polymorphisms in Gulf War Illness (GWI)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00810225
Enrollment
516
Registered
2008-12-18
Start date
2008-08-31
Completion date
2011-07-31
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gulf War Illness, Persian Gulf War Syndrome

Keywords

CNDP1, carnosine dipeptidase 1, Persian Gulf War, Gulf War Syndrome, GWI, Gulf War Illness, Exercise, Chronic Fatigue, Fibromyalgia, Veterans, Irritable Bowel Syndrome, Migraine headaches, Neuropathy, Multiple Chemical Sensitivity

Brief summary

Determine if: * genetic differences of CNDP1 gene * the previously defined GWI/Chronic Fatigue Syndrome (GWI/CFS) cerebrospinal fluid proteome contents * psychometric * other variables can differentiate between veterans of the 1990-1991 Persian Gulf War who have autonomic, neurological and other symptoms and those without these complaints.

Interventions

None listed

Sponsors

U.S. Army Medical Research and Development Command
CollaboratorFED
Georgetown University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Evidence of military enlistment between August 1, 1990 and July 31, 1991, and deployment for 30 consecutive days to: * Persian Gulf waters and adjacent land areas * Other global locations * U.S. only * Status prior to 1990 and 1991: * Active duty * National Guard * Reserves

Exclusion criteria

* Current active duty military personnel * Any one who was not active duty military personnel between August 1, 1990 and July 31, 1991 * HIV/AIDS; pregnancy or lactation; potential hepatitis; drug addiction; chronic inflammatory, infectious, or autoimmune medical illnesses not associated with GWI; incarceration; dementia, other cognitive limitation; or reliance on a care-giver in order to respond to the questionnaires and other study tests. Amputations of one or both hands and forearms will be permitted but hand grip tests will not be tested

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026